MergerLinks Header Logo

Announced

Charme Capital Partners to acquire a majority stake in Tema Sinergie.

Synopsis

Charme Capital Partners, a mid-market private equity fund, agreed to acquire a majority stake in Tema Sinergie, a manufacturer of innovative products for nuclear medicine applications. Financial terms were not disclosed. "Charme IV's investment in Tema Sinergie is totally consistent with Charme Funds strategy of investing, in partnership with their respective founders and managers, in excellent entrepreneurial companies with strong growth potential. The leadership and vision of the founders and of Stefano Piancastelli are, in total continuity, the pillars of the significant growth envisaged in the strategic plan of Tema Sinergie," Tommaso Beolchini, Charme Founding Partner.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite